MedTrace Logo

Significance of Immunohistochemical Expression of Survivin in Renal Cell Carcinoma

NCT04873180 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 40

Last updated 2021-05-07

No results posted yet for this study

Summary

detection of Survivin expression in renal cell carcinoma and correlate this expression to tumor grade and stage.

Conditions

Interventions

DIAGNOSTIC_TEST

sectioning and staining of renal neoplasms after nephrectomy operation

nephrectomy operations will be done to patients diagnosed as having renel tumors

Sponsors & Collaborators

  • Sohag University

    lead OTHER

Principal Investigators

  • Maisa H Mohammed, MD · a lecturer of pathology, Sohag faculty of medicine

Eligibility

Min Age
30 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-01-01
Primary Completion
2020-06-30
Completion
2020-12-30

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04873180 on ClinicalTrials.gov